您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > Taurine-d4
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Taurine-d4
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Taurine-d4图片
规格:98%
分子量:129.2
包装与价格:
包装价格(元)
500ug电议
1mg电议
5mg电议
10mg电议

产品介绍
An internal standard for the quantification of taurine
货号:ajcx25808
CAS:342611-14-7
分子式:C2H3D4NO3S
分子量:129.2
溶解度:PBS (pH 7.2): 10 mg/ml
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Taurine-d4is intended for use as an internal standard for the quantification of taurine by GC- or LC-MS. Taurine is a sulfur-containing amino acid produced endogenously and also ingested in the diet.1It is ubiquitously present in most cells and has diverse biological activities, including antioxidative, anticancer, cardioprotective, and neuroprotective properties.1,2,3,4It scavenges 2,2-diphenyl-1-picrylhydrazyl radicals when used at concentrations ranging from 125 to 1,000 µg/ml and decreases the viability of MCF-7 and MDA-MB-231 human breast cancer cells.2It prevents left ventricular dysfunction in the mdx mouse model of late-stage Duchenne muscular dystrophy when administered at a dose of 1 g/kg per day for six months.3Taurine (100 µM) prevents neurotoxicity induced by amyloid-β (Aβ) or the glutamate receptor agonists glutamate, NMDA , or kainic acid in chick embryonic retinal neurons, an effect that can be blocked by the GABAAreceptor antagonist picrotoxin .4


1.Schaffer, S., and Kim, H.W.Effects and mechanisms of taurine as a therapeutic agentBiomol. Ther. (Seoul)26(3)225-241(2018) 2.Choi, E.-J., Tang, Y., Lee, C.B., et al.Investigation of antioxidant and anticancer potential of taurine by means of multiple chemical and biological assaysTaurine 9(2018) 3.Mele, A., Manturano, P., De Bellis, M., et al.A long-term treatment with taurine prevents cardiac dysfunction in mdx miceTransl. Res.20482-99(2019) 4.Louzada, P.R., Lima, A.C.P., MendonÇa-Silva, D.L., et al.Taurine prevents the neurotoxicity of ß-amyloid and glutamate receptor agonists: Activation of GABA receptors and possible implications for Alzheimer’s disease and other neurological disordersFASEB J.18(3)511-518(2004)